{"success":true,"data":{"pressRelease":{"id":"133777","rtpr_id":"nACS27FYna","ticker":"DM","exchange":"","all_tickers":["DM"],"title":"Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing","author":"ACCESSWIRE","published_at":"2026-09-02T12:00:00.966Z","article_body":"TORONTO, ON / ACCESS Newswire (https://www.accessnewswire.com/) / September 2,\n2026 / Datametrex AI Limited (the \"Company\" or \"Datametrex'')\n(TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has\ninitiated plans to wind down its health care operations.\n\nThe wind-down is intended to allow the Company to focus its resources and\nmanagement efforts on its core AI, data centre technology, and patent\nlicensing businesses, optimize its current operations and resources, reduce\noperating and regulatory compliance requirements, and improve overall\nfinancial performance.\n\nAs part of the wind-down process, the Company intends to gradually reduce and\nultimately cease its health care operations, including the operation of its\nmulti-disciplinary medical clinics in Edmonton and Calgary, Alberta, and\nVancouver, British Columbia. These clinics currently provide a range of health\ncare and related services, including primary and emergency care.\n\nThe Company will take a measured and orderly approach to the wind-down\nprocess, with the timing and scope of the reduction of operations determined\nbased on operational, financial, contractual and regulatory considerations.\nThe Company intends to manage the transition in an orderly manner and will\ncontinue to assess opportunities to maximize value from its health care assets\nand operations during the wind-down process.\n\nThe Company expects the wind-down of its health care operations to allow\nQuanta AI to simplify its corporate structure and focus on its AI, data centre\ntechnology, and patent licensing businesses. The Company believes that this\nstrategic focus will allow management to allocate capital and resources toward\nits core business areas and pursue opportunities that are aligned with the\nCompany's long-term objectives. In this regard, its patent licensing\ninitiatives remain active. The Company will be making further announcements,\nas events warrant.\n\nAbout Datametrex\n\nDatametrex is an innovative leader in Technology Solutions, Artificial\nIntelligence, and Healthcare. The Company specializes in delivering tools and\nsolutions that enhance operational efficiencies and business outcomes. With a\ncommitment to innovation, Datametrex is dedicated to supporting enterprises by\nsetting a new standard for business protocols through cutting-edge technology.\n\nFor more on Datametrex, please visit our Company website\n(https://pr.report/prxh) (www.datametrex.com).\n\nFor Additional Information\n\nMichael Kron\nCEO & Chairman\ninfo@datametrex.com\n416-901-5611\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in the policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nForward-Looking Statements\n\nThis news release contains \"forward-looking statements,\" which involve risks,\nuncertainties, and factors that could cause actual results to differ\nmaterially from those anticipated. These statements are not historical facts\nand are generally identified by words such as \"expects,\" \"plans,\"\n\"anticipates,\" \"believes,\" \"intends,\" \"estimates,\" \"projects,\" and similar\nexpressions. Such statements include expectations related to the Company plans\nand performance.\n\nForward-looking statements are neither historical facts nor assurances of\nfuture performance. Instead, they are based only on our current beliefs,\nexpectations and assumptions regarding the future of our business, future\nplans and strategies, projections, anticipated events and trends, the economy\nand other future conditions. Because forward-looking statements relate to the\nfuture, they are subject to inherent uncertainties, risks and changes in\ncircumstances that are difficult to predict and many of which are outside of\nour control. Our actual results and financial condition may differ materially\nfrom those indicated in the forward-looking statements. Therefore, you should\nnot rely on any of these forward-looking statements.\n\nWhile Datametrex believes the forward-looking information is reasonable as of\nthe date of this release, these statements involve assumptions, risks, and\nuncertainties that could cause actual outcomes to differ. Key factors include\ngeneral economic conditions, legislative and regulatory developments, access\nto capital, industry competition, and the Company's ability to execute its\nstrategies. Except as required by applicable securities laws, we undertake no\nobligation to publicly update any forward-looking statement, whether written\nor oral, that may be made from time to time, whether as a result of new\ninformation, future developments or otherwise.\n\nReaders are advised not to place undue reliance on forward-looking\ninformation.\n\nFactors that could cause actual results to differ materially are detailed\nunder \"Risk Factors\" in Datametrex's management's discussion and analysis and\navailable on the Company's profile at www.sedarplus.ca.\n\nThis release does not constitute an offer to sell or a solicitation to buy,\nnor shall it constitute an offer, solicitation, or sale in any jurisdiction\nwhere such would be unlawful prior to registration or qualification under\napplicable securities laws. We seek Safe Harbor.\n\nSOURCE: Datametrex AI Ltd.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/datametrex-plans-to-focus-on-ai-data-centre-and-patent-licensing-1215156)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACS27FYna","title":"Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing","author":"ACCESSWIRE","ticker":"DM","created":"2026-09-02T12:00:00.966Z","tickers":["DM"],"exchange":"","article_body":"TORONTO, ON / ACCESS Newswire (https://www.accessnewswire.com/) / September 2,\n2026 / Datametrex AI Limited (the \"Company\" or \"Datametrex'')\n(TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has\ninitiated plans to wind down its health care operations.\n\nThe wind-down is intended to allow the Company to focus its resources and\nmanagement efforts on its core AI, data centre technology, and patent\nlicensing businesses, optimize its current operations and resources, reduce\noperating and regulatory compliance requirements, and improve overall\nfinancial performance.\n\nAs part of the wind-down process, the Company intends to gradually reduce and\nultimately cease its health care operations, including the operation of its\nmulti-disciplinary medical clinics in Edmonton and Calgary, Alberta, and\nVancouver, British Columbia. These clinics currently provide a range of health\ncare and related services, including primary and emergency care.\n\nThe Company will take a measured and orderly approach to the wind-down\nprocess, with the timing and scope of the reduction of operations determined\nbased on operational, financial, contractual and regulatory considerations.\nThe Company intends to manage the transition in an orderly manner and will\ncontinue to assess opportunities to maximize value from its health care assets\nand operations during the wind-down process.\n\nThe Company expects the wind-down of its health care operations to allow\nQuanta AI to simplify its corporate structure and focus on its AI, data centre\ntechnology, and patent licensing businesses. The Company believes that this\nstrategic focus will allow management to allocate capital and resources toward\nits core business areas and pursue opportunities that are aligned with the\nCompany's long-term objectives. In this regard, its patent licensing\ninitiatives remain active. The Company will be making further announcements,\nas events warrant.\n\nAbout Datametrex\n\nDatametrex is an innovative leader in Technology Solutions, Artificial\nIntelligence, and Healthcare. The Company specializes in delivering tools and\nsolutions that enhance operational efficiencies and business outcomes. With a\ncommitment to innovation, Datametrex is dedicated to supporting enterprises by\nsetting a new standard for business protocols through cutting-edge technology.\n\nFor more on Datametrex, please visit our Company website\n(https://pr.report/prxh) (www.datametrex.com).\n\nFor Additional Information\n\nMichael Kron\nCEO & Chairman\ninfo@datametrex.com\n416-901-5611\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in the policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nForward-Looking Statements\n\nThis news release contains \"forward-looking statements,\" which involve risks,\nuncertainties, and factors that could cause actual results to differ\nmaterially from those anticipated. These statements are not historical facts\nand are generally identified by words such as \"expects,\" \"plans,\"\n\"anticipates,\" \"believes,\" \"intends,\" \"estimates,\" \"projects,\" and similar\nexpressions. Such statements include expectations related to the Company plans\nand performance.\n\nForward-looking statements are neither historical facts nor assurances of\nfuture performance. Instead, they are based only on our current beliefs,\nexpectations and assumptions regarding the future of our business, future\nplans and strategies, projections, anticipated events and trends, the economy\nand other future conditions. Because forward-looking statements relate to the\nfuture, they are subject to inherent uncertainties, risks and changes in\ncircumstances that are difficult to predict and many of which are outside of\nour control. Our actual results and financial condition may differ materially\nfrom those indicated in the forward-looking statements. Therefore, you should\nnot rely on any of these forward-looking statements.\n\nWhile Datametrex believes the forward-looking information is reasonable as of\nthe date of this release, these statements involve assumptions, risks, and\nuncertainties that could cause actual outcomes to differ. Key factors include\ngeneral economic conditions, legislative and regulatory developments, access\nto capital, industry competition, and the Company's ability to execute its\nstrategies. Except as required by applicable securities laws, we undertake no\nobligation to publicly update any forward-looking statement, whether written\nor oral, that may be made from time to time, whether as a result of new\ninformation, future developments or otherwise.\n\nReaders are advised not to place undue reliance on forward-looking\ninformation.\n\nFactors that could cause actual results to differ materially are detailed\nunder \"Risk Factors\" in Datametrex's management's discussion and analysis and\navailable on the Company's profile at www.sedarplus.ca.\n\nThis release does not constitute an offer to sell or a solicitation to buy,\nnor shall it constitute an offer, solicitation, or sale in any jurisdiction\nwhere such would be unlawful prior to registration or qualification under\napplicable securities laws. We seek Safe Harbor.\n\nSOURCE: Datametrex AI Ltd.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/datametrex-plans-to-focus-on-ai-data-centre-and-patent-licensing-1215156)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-09-02T12:00:01.042885865Z","server_sent_at_ms":1788350401042},"received_at":"2026-09-02T12:00:01.128Z","source_url":"https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/datametrex-plans-to-focus-on-ai-data-centre-and-patent-licensing-1215156"},"analysis":{"id":"122670","press_release_id":"133777","analysis_json":{"industry":{"label":"IT Services","sector":"Information Technology"},"redFlags":["Exit of an entire revenue-generating healthcare segment with no disclosed timeline or expected costs/charges","Release states the wind-down will allow 'Quanta AI' to simplify its corporate structure rather than Datametrex itself -- potential parent/subsidiary restructuring or naming inconsistency worth verifying","No quantification of expected financial impact or value expected from healthcare asset disposition"],"eventType":"restructuring","narrative":"Datametrex AI Limited has initiated plans to wind down its health care operations, gradually ceasing its multi-disciplinary medical clinics in Edmonton, Calgary, and Vancouver, which provide primary and emergency care.\n\nThe exit is intended to free resources for the company's core AI, data centre technology, and patent licensing businesses, with management citing lower operating and regulatory compliance requirements and improved financial performance as the goals.\n\nNo timeline, expected charges, or financial figures were disclosed; the release notes patent licensing initiatives remain active and further announcements will follow as events warrant.","sentiment":"mixed","agentHooks":{"shouldPost":false,"suggestedAngle":"Small-cap pivot: Datametrex exits healthcare clinics entirely to concentrate on AI, data centres, and patent licensing -- watch for timing details and asset value recovery."},"keyFigures":{},"quotedText":"initiated plans to wind down its health care operations","namedEntities":{"people":[{"name":"Michael Kron","role":"CEO & Chairman"}],"products":[],"companies":[{"name":"Datametrex AI Limited","ticker":"DM","relationship":"filer"},{"name":"Quanta AI","relationship":"related entity referenced in corporate-structure rationale (role unclear from release)"}],"dollarAmounts":[]},"materialImpact":{"score":3,"reasoning":"Full exit of the healthcare segment -- revenue-generating medical clinics in three cities -- is a material strategic restructuring for a small-cap filer. However, no timeline, expected charges, or financial figures are disclosed, and the wind-down is framed as gradual and orderly."},"tickerRelevance":{"others":[{"ticker":"DTMXF","relevance":"same issuer, OTC Pink listing"},{"ticker":"D4G","relevance":"same issuer, Frankfurt listing"}],"primary":"DM"},"globalImportance":22,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap (TSXV / OTC Pink / Frankfurt)","eventGravity":"full segment exit / strategic pivot to AI and data centres","issuerAuthored":true,"householdBrandBoost":"none","marketCapAdjustment":"small-cap discount applied","financialDetailDeficit":"no figures or timeline disclosed, caps the score"}},"event_type":"restructuring","event_type_secondary":null,"sentiment":"mixed","material_impact_score":3,"narrative":"Datametrex AI Limited has initiated plans to wind down its health care operations, gradually ceasing its multi-disciplinary medical clinics in Edmonton, Calgary, and Vancouver, which provide primary and emergency care.\n\nThe exit is intended to free resources for the company's core AI, data centre technology, and patent licensing businesses, with management citing lower operating and regulatory compliance requirements and improved financial performance as the goals.\n\nNo timeline, expected charges, or financial figures were disclosed; the release notes patent licensing initiatives remain active and further announcements will follow as events warrant.","key_figures":{},"named_entities":{"people":[{"name":"Michael Kron","role":"CEO & Chairman"}],"products":[],"companies":[{"name":"Datametrex AI Limited","ticker":"DM","relationship":"filer"},{"name":"Quanta AI","relationship":"related entity referenced in corporate-structure rationale (role unclear from release)"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-02T13:01:44.383Z","global_importance":22,"audience_relevance":12,"importance_components":{"tickerTier":"micro-cap (TSXV / OTC Pink / Frankfurt)","eventGravity":"full segment exit / strategic pivot to AI and data centres","issuerAuthored":true,"householdBrandBoost":"none","marketCapAdjustment":"small-cap discount applied","financialDetailDeficit":"no figures or timeline disclosed, caps the score"}},"durationMs":null,"modelName":"glm-4.7"}}